Thrombosis origin identification of cardioembolism and large artery atherosclerosis by distinct metabolites

Wei Li1,2,3, Xuesong Bai1,3, Jiheng Hao2

  • 1Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Insights

Six distinct metabolites can now differentiate between cardioembolic and large artery atherosclerosis cerebral thrombosis. This finding aids in understanding stroke causes and preventing future events.

Area of Science:

  • Biochemistry
  • Neurology
  • Medical Diagnostics

Background:

  • Diagnosing the origin of cerebral thrombosis is challenging.
  • Distinguishing between cardioembolism (CE) and large artery atherosclerosis (LAA) is crucial for effective treatment.
  • Metabolomic profiling offers a novel approach to identify distinct biomarkers.

Purpose of the Study:

  • To identify distinct metabolites differentiating CE and LAA cerebral thrombi.
  • To develop a predictive model for classifying thrombosis origins using identified metabolites.
  • To enhance understanding of the pathogenesis of different stroke types.

Main Methods:

  • Ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) was used to analyze thrombi metabolites.
  • Machine learning classifiers, including random forest (RF), were employed to build and evaluate predictive models.
  • Metabolite data from 26 CE and 22 LAA thrombi were analyzed.

Main Results:

  • Significant differences in metabolite levels and enriched metabolic pathways were observed between CE and LAA thrombi.
  • Six key metabolites were identified as potential predictors for distinguishing thrombosis origins.
  • A random forest model demonstrated high predictive accuracy (AUC=0.889) for classifying thrombosis types.

Conclusions:

  • Six specific metabolites serve as reliable predictors for differentiating cerebral thrombi of CE and LAA origin.
  • These findings contribute to a better understanding of stroke pathogenesis.
  • The identified biomarkers are valuable for secondary stroke prevention strategies.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
49
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
357
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
27
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
99
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
47
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
74